Literature DB >> 23052973

Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury.

Stuart M Grieve1, Jacob Lønborg, Jawad Mazhar, Timothy C Tan, Edwin Ho, Chia-Chi Liu, William Lay, Anthony J Gill, Philip Kuchel, Ravinay Bhindi, Gemma A Figtree.   

Abstract

Inflammatory response plays an important role in myocardial ischaemia-reperfusion (IR) injury. Up-regulation of vascular cell adhesion molecule-1 (VCAM) contributes to this. We examined the feasibility of using intravenously administered VCAM-MPIO (microparticle iron oxide) to characterize VCAM expression patterns in myocardial IR injury. Myocardial ischemia was simulated by 30 min of transient ligation of the left coronary vessel in rats. Purified, monoclonal, rat-specific, mouse VCAM antibody coupled to MPIO was administered through the tail vein at 3 h post reperfusion and the rats were sacrificed 1 h later. High resolution 3D ex vivo MRI images were acquired at 9.4 Tesla. Extensive foci of signal voids were observed on T2*-weighted gradient-echo sequences, which corresponded to focal deposits of MPIOs observed in histological sections. The spatial density of the signal voids (expressed as a percentage of pixels below a threshold value) was increased in the peri-infarct zone compared with non-infarct zone (32.5 ± 4% vs. 13.9 ± 5%; n = 6; p < 0.05) and was substantially greater than the signal loss due to non-specific binding seen in rats administered IgG control MPIO (2.0 ± 1%; n = 6; p < 0.05). The VCAM-specific MPIO signal was also seen in myocardium and pericardium in segments remote from the IR injury, but not in rats undergoing a sham operation. In conclusion, molecular imaging in a model of myocardial IR injury is possible using high field MRI and VCAM-MPIOs and may provide novel insights beyond those achieved by standard histological and molecular analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052973     DOI: 10.1007/s00249-012-0857-x

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  38 in total

Review 1.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

2.  Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats.

Authors:  R Hayward; B Campbell; Y K Shin; R Scalia; A M Lefer
Journal:  Cardiovasc Res       Date:  1999-01       Impact factor: 10.787

3.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

4.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.

Authors:  M R Litt; R W Jeremy; H F Weisman; J A Winkelstein; L C Becker
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

5.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

6.  Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure.

Authors:  David E Sosnovik; Matthias Nahrendorf; Peter Panizzi; Takashi Matsui; Elena Aikawa; Guangping Dai; Ling Li; Fred Reynolds; Gerald W Dorn; Ralph Weissleder; Lee Josephson; Anthony Rosenzweig
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-01       Impact factor: 7.792

7.  Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis.

Authors:  C von zur Muhlen; D von Elverfeldt; J A Moeller; R P Choudhury; D Paul; C E Hagemeyer; M Olschewski; A Becker; I Neudorfer; N Bassler; M Schwarz; C Bode; K Peter
Journal:  Circulation       Date:  2008-06-23       Impact factor: 29.690

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

Authors:  Matthias Nahrendorf; David Sosnovik; John W Chen; Peter Panizzi; Jose-Luiz Figueiredo; Elena Aikawa; Peter Libby; Filip K Swirski; Ralph Weissleder
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium.

Authors:  Anders Gabrielsen; Patrick R Lawler; Wang Yongzhong; Daniel Steinbrüchel; Dimo Blagoja; Gabrielle Paulsson-Berne; Jens Kastrup; Göran K Hansson
Journal:  J Mol Cell Cardiol       Date:  2007-01-08       Impact factor: 5.000

View more
  7 in total

1.  Particle generation, functionalization and sortase A-mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use.

Authors:  Christoph E Hagemeyer; Karen Alt; Angus P R Johnston; Georgina K Such; Hang T Ta; Melissa K M Leung; Sandeep Prabhu; Xiaowei Wang; Frank Caruso; Karlheinz Peter
Journal:  Nat Protoc       Date:  2014-12-11       Impact factor: 13.491

2.  Automated quantification of myocardial salvage in a rat model of ischemia-reperfusion injury using 3D high-resolution magnetic resonance imaging (MRI).

Authors:  Stuart M Grieve; Jawad Mazhar; Fraser Callaghan; Cindy Y Kok; Sarah Tandy; Ravinay Bhindi; Gemma A Figtree
Journal:  J Am Heart Assoc       Date:  2014-07-23       Impact factor: 5.501

Review 3.  Molecular magnetic resonance imaging of brain-immune interactions.

Authors:  Maxime Gauberti; Axel Montagne; Aurélien Quenault; Denis Vivien
Journal:  Front Cell Neurosci       Date:  2014-11-27       Impact factor: 5.505

4.  Exogenous microparticles of iron oxide bind to activated endothelial cells but, unlike monocytes, do not trigger an endothelial response.

Authors:  Andrew Jefferson; Neil Ruparelia; Robin P Choudhury
Journal:  Theranostics       Date:  2013-05-25       Impact factor: 11.556

5.  Nanoparticle delivery of cardioprotective therapies.

Authors:  Abraham Mendez-Fernandez; Hector A Cabrera-Fuentes; Bhaarathy Velmurugan; Jason Irei; William A Boisvert; Shengjie Lu; Derek J Hausenloy
Journal:  Cond Med       Date:  2020-02

Review 6.  Cardiovascular imaging: what have we learned from animal models?

Authors:  Arnoldo Santos; Leticia Fernández-Friera; María Villalba; Beatriz López-Melgar; Samuel España; Jesús Mateo; Ruben A Mota; Jesús Jiménez-Borreguero; Jesús Ruiz-Cabello
Journal:  Front Pharmacol       Date:  2015-10-21       Impact factor: 5.810

7.  Oral pre-treatment with thiocyanate (SCN-) protects against myocardial ischaemia-reperfusion injury in rats.

Authors:  Luke Hall; Chaouri Guo; Sarah Tandy; Kathryn Broadhouse; Anthony C Dona; Ernst Malle; Emil D Bartels; Christina Christoffersen; Stuart M Grieve; Gemma Figtree; Clare L Hawkins; Michael J Davies
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.